The Patent Finder

Acasti Pharma U.S., Inc.

Also on record
Records under this name other than the patents Acasti Pharma U.S., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 7 of 7 · Back to Acasti Pharma U.S., Inc.

PatentTitleStatus Expires Confidence
US 8,586,567Concentrated Therapeutic Phospholipid Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,475,830Concentrated Therapeutic Phospholipid Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,130,644Concentrated Therapeutic Phospholipid Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,194,064Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,414,943Nimodipine parenteral administration
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,326,922Apparatus for metering and dispensing viscous substance
Formerly held
Lapsed on the fee record
Ended May 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 10, 2026From the USPTO record
US 10,617,702Concentrated Therapeutic Phospholipid Compositions
Formerly held
Lapsed on the fee record
Ended Apr 14, 2024 · Medium confidence
Lapsed on the fee recordEnded Apr 14, 2024Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited